Viewing StudyNCT00330369



Ignite Creation Date: 2024-05-05 @ 4:53 PM
Last Modification Date: 2024-10-26 @ 9:25 AM
Study NCT ID: NCT00330369
Status: COMPLETED
Last Update Posted: 2014-03-18
First Post: 2006-05-24

Brief Title: DORADO - Fixed Doses of Darusentan as Compared to Placebo in Resistant Hypertension
Sponsor: Gilead Sciences
Organization: Gilead Sciences

Key Dates - Follows AllAPIJSON File Order

Start Date: 2006-06
Start Date Type: None
Primary Completion Date: 2009-01
Primary Completion Date Type: ACTUAL
Completion Date: 2009-01
Completion Date Type: ACTUAL
First Submit Date: 2006-05-24
First Submit QC Date: May 24 2006
Study First Post Date: 2006-05-26
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: 2014-01-03
Disp First Submit QC Date: January 3 2014
Disp First Post Date: 2014-02-04
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2014-02-19
Last Update Post Date: 2014-03-18
Last Update Post Date Type: ESTIMATED